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AbstrACt
Introduction Suicide attempt is the most important 
risk factor for later suicide. A randomised-controlled, 
multicentre trial of postsuicide attempt case management 
for the prevention of further suicide attempts in Japan, 
named ACTION-J, has established effective interventions 
for prevention of suicide reattempts. The ACTION-J 
assertive case management intervention programme 
was adopted by the Japanese Ministry of Health, Labour 
and Welfare in 2016, when medical fees were revised. 
This nationwide programme is provided to patients who 
attempt suicide and who are admitted to emergency 
departments in Japan. The aim of the present study 
is to examine the current implementation status of the 
ACTION-J programme. The present study also aims to 
clarify which patients’ and hospitals’ factors affect the 
implementation of the programme.
Methods and analysis This is a prospective, multicentre, 
patient registry cohort study. Participants will be suicide 
attempters admitted to the emergency departments of 
medical facilities with both psychiatry and emergency 
departments. The assertive case management programme 
will be delivered to participants by a case manager for up 
to 24 weeks, based on psychiatric diagnoses, social risks 
and patient needs. The core feature of the programme 
is to encourage patients to participate in psychiatric 
treatment. The primary outcome will be the proportion 
of patients still participating in the case management 
intervention at 24 weeks after registration. The secondary 
outcomes will include measures of the fidelity of the case 
management intervention. The fidelity will be evaluated 
using a fidelity assessment manual developed by the study 
group.
Ethics and dissemination This observational study 
has been approved by the ethics board of Sapporo 
Medical University. Enrolment began in October 2016 
and will continue until December 2018. Dissemination 
plans include presentations at scientific conferences and 
scientific publications.
trial registration UMIN000024474.
IntroduCtIon
background and rationale
Suicide attempt is the most important risk 
factor for later suicide.1–3 There have been 
many efforts to establish effective interven-
tions to prevent suicide reattempts, such as 
a randomised-controlled trial conducted by 
Morthorst et al (2013), which tested the effec-
tiveness of the assertive case management 
intervention.4–7 Case management seems to 
be effective for individuals, such as suicide 
attempters, with multiple suicide risk factors. 
However, Morthorst et al’s intervention did 
not result in a significant reduction in suicide 
attempts, possibly because of the small sample 
size.
Patients who are severely and physically 
impaired following a suicide attempt are 
admitted to tertiary emergency departments 
to receive physical care. In the early 2000s, 
the Advanced Critical Care and Emergency 
strengths and limitations of this study
 ► This study is conducted in real clinical world set-
tings involving both emergency and psychiatric 
departments.
 ► The assertive case management intervention pro-
gramme given to suicide attempters has been 
already proved feasible and effective by a ran-
domised-controlled trial.
 ► The number of medical facilities participating in this 
study is limited.
 o
n
 16 January 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-020517 on 4 October 2018. Downloaded from 
2 Kawanishi C, et al. BMJ Open 2018;8:e020517. doi:10.1136/bmjopen-2017-020517
Open access 
Centre of the Yokohama City University Medical Centre 
began offering psychological crisis intervention and 
psychiatric assessments, as well as case management inter-
ventions, and demonstrated the effectiveness of this type 
of intervention model.8 Thus, in 2005, a randomised-con-
trolled, multicentre trial of postsuicide attempt case 
management for the prevention of further suicide 
attempts in Japan, named ACTION-J,9 10 was conducted 
as part of the Ministry of Health, Labour and Welfare’s 
‘Strategic research projects’, which aimed to formulate 
national policies for pressing health issues in Japan, such 
as suicide. The ACTION-J research group consisted of 17 
Japanese hospitals with both an emergency department 
and a psychiatric department. Potential study partic-
ipants were suicide attempters who had been admitted 
to the emergency department and received critical care. 
After the crisis intervention, an assertive case manage-
ment intervention, which includes psychoeducation, was 
provided by trained case managers. The intervention was 
based on psychiatric diagnoses, social risks and patient 
needs during the patients’ stay in the emergency depart-
ments and continued for at least 1.5 years after discharge. 
The core feature of the programme was to encourage 
patients to participate in psychiatric treatment (table 1). 
The primary outcome of the trial was the first recurrence 
of suicidal behaviour (attempted suicide or completed 
suicide).9 A total of 914 participants was enrolled in the 
trial. The results showed that the cumulative incidence of 
first recurrent suicidal behaviour was significantly lower in 
the assertive case management intervention group than in 
the control group.10 Therefore, the assertive intervention 
programme was adopted to the medical payment scheme 
by the Japanese Ministry of Health, Labour and Welfare 
in 2016, when medical fees were revised. The interven-
tion is provided to suicide attempt patients admitted to 
emergency departments in Japan.
specific aim
The present study aims to examine the current implemen-
tation status of the ACTION-J intervention programme 
and to determine whether the ACTION-J assertive 
case management programme works in a real world 
clinical setting. The present study also aims to clarify 
which patients’ or hospitals’ factors and psychological 
measures affect the implementation of the intervention 
programme.
significance
Suicide attempt is the most important risk factor for later 
suicide.
MEthods And AnAlysIs
study design
The post-ACTION-J Study (PACS) is a prospective, multi-
centre, patient registry cohort study. Each participating 
medical facility has both psychiatry and emergency 
departments. These facilities also have a case manager 
who implements the assertive case management interven-
tion derived from the ACTION-J trial10 with psychiatrists 
and other medical personnel in each facility. Baseline 
data of each participating hospital were used to estimate 
the number of participants as 200.
recruitment and task schedule
Potential study participants in this cohort are suicide 
attempters admitted to the emergency departments of 
nine participating medical facilities (see online supple-
mentary appendix). While the suicide attempters receive 
critical care, the emergency doctors will consult psychi-
atrists. After suicide attempters have been physically 
stabilised and alert consciousness has been confirmed, 
potential study participants will receive thorough psycho-
social assessment, including evaluations of the social, 
psychological and motivational factors specific to the 
self-harm event and an assessment of mental health, 
social risks and needs. The trained psychiatrists in the 
study group will check the inclusion and exclusion 
criteria. They will provide potential study participants 
with a complete description of this study, and ask them 
to give their informed consent. Then, the psychiatrists or 
other trained medical study group personnel will admin-
ister semistructured psychoeducation developed by the 
ACTION-J Trial.10 After the psychoeducation session, 
patients will be provided with an information pamphlet 
in which social resources (eg, healthcare sector and 
consultation services provided by local governments) are 
listed. The assertive and continuous case management 
Table 1 Features of the assertive case management intervention derived from the ACTION-J trial
1. Periodic contact (either face-to-face or via telephone) with participants at the participating hospitals during their stay at 
the emergency department and after discharge
2. Collection of information about each participant’s treatment status and social problems that could disturb their treatment 
adherence
3. Encouragement of participants to adhere to psychiatric treatment
4. Coordination of appointments with psychiatrists and primary care physicians
5. Encouragement of participants who discontinued receiving psychiatric treatment to return to treatment
6. Referrals to social services and private support organisations and coordination for use of these resources to 
accommodate their individual needs
7. Provision of the content of psychoeducation and the information about social resources through a dedicated website
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intervention (table 1) will then be offered to partici-
pants by officially trained case managers (psychiatric 
social workers or clinical psychologists). Psychoeduca-
tion will also be provided to family members during the 
participants’ hospital stay. The case management inter-
vention will be provided during their hospital stay and 
provided periodically after discharge. The case manager 
will contact participants at the hospital every month for 6 
months after registration. The assertive case management 
intervention will be implemented through direct face-to-
face dialogue. Table 1 shows the assertive case manage-
ment programme.
study participants
The PACS will target individuals admitted to the emer-
gency departments of nine participating medical facilities 
because of suicide attempts.
Inclusion/exclusion criteria
The inclusion criteria are: (1) Individuals admitted 
to an emergency department and assessed by physicians 
as likely to have inflicted self-injury. (2) Individuals with 
self-injury who are confirmed as having suicidal ideation 
according to multiple psychiatric assessments. (3) Indi-
viduals who provide informed consent for participation 
in the ACTION-J intervention programme.
Exclusion criteria are: (1) Individuals with impaired 
consciousness at the time of informed consent. (2) Indi-
viduals who do not understand Japanese. (3) Individuals 
who are unsuitable for registration in the present study 
for any other reasons.
data collection
The data collection process will be as follows (the schedule 
is shown in table 2):
Basic patient data
This will comprise initials, ID, age, sex, cohabitants, 
marital status, education, employment status, family 
history, advisor, history of medical treatment and drinking 
habits.
Psychiatric evaluation
Psychiatric evaluation will comprise index suicide attempt, 
history of psychiatric care and psychiatric diagnosis made 
by at least two psychiatrists according to the criteria of the 
Diagnostic and Statistical Manual of Mental Disorders, 
fifth edition.
Detailed case management information
This will comprise any clinical records.
Survival, suicide reattempts, self-harm
This will comprise number of survivals and any events, 
including suicide reattempts, deliberate self-harm and 
suicide ideation.
Treatment adherence
Information about psychiatric treatment and any medical 
treatment will be recorded. T
ab
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Psychological measures
Buss-Perry Aggression Questionnaire (BAQ): Aggression 
is a key personality trait and a risk factor associated with 
suicidal behaviour. The BAQ is one of the most widely 
used tests for measuring trait aggression.11–13
Barratt Impulsiveness Scale (BIS): Impulsivity is a key 
personality trait and a risk factor associated with suicidal 
behaviour. The BIS is one of the most widely used tests for 
measuring trait impulsivity.14 15
Columbia-Suicide Severity Rating Scale (C-SSRS): The 
C-SSRS is a standardised measure that permits compre-
hensive assessment of suicidal behaviour and ideation.16
Beck Depression Inventory-II (BDI-II): The BDI-II is 
one of the most widely used tests for measuring severity 
of depression.17
Fidelity assessment of case management intervention
The outcomes include measurement of the fidelity of 
the case management intervention. This is crucial in 
assessing to what extent the intervention prevents suicide 
reattempts. Fidelity will be evaluated using the fidelity 
assessment manual developed by the study group. The 
development process and interval validation of this 
measure will be reported.
outcomes
Outcome measures are as follows:
Primary outcome
This is the proportion of the study sample still partici-
pating in the continued case management intervention 
at 24 weeks (6 months) after registration.
Secondary outcomes
1. The following items will be assessed at 24 weeks (6 
months) after registration:
1. Incidence rate (person-years) and proportion of 
deaths (suicides and any cause), first recurrent sui-
cide attempts/self-injury and frequency of suicide 
attempts/self-injury
2. Scores on fidelity assessment of case management 
intervention
3. Proportion of treatment adherence
4. BAQ scores
5. BIS scores
6. Difference in C-SSRS scores from baseline to 24 
weeks
7. Difference in BDI-II scores from baseline to 24 
weeks
2. The following items will be assessed at 18 months 
postregistration:
Incidence rate and proportion of deaths (suicides or 
any cause), first recurrent suicide attempts/self-injury 
and frequency of suicide attempts/self-injury
None of the outcome assessments will be blinded.
stages of the study
Study period: October 2016 through March 2021
Registration: 31 December 2018
Follow-up: 30 June 2019
statistical analysis plan
The analysis will be of an exploratory nature. The primary 
analysis will be based on all the available patient data and 
will measure the primary outcome. Multivariable logistic 
regression models will be used to estimate ORs to obtain 
predictive factors from the binary data. Multivariable 
Poisson regression models will be used to obtain the inci-
dence rate ratio for frequency of suicide attempts. Then, a 
zero-inflated Poisson model will be used if the data warrant 
it. Multivariable linear regression will be performed 
on the continuous variables (psychological measures). 
Predictors such as age, sex, cohabitants, marital status, 
education, employment status, family history, advisor, 
history of medical treatment, drinking habits, C-SSRS, 
BDI-II and psychiatric diagnosis will be included into the 
models. Backward variable selection will be used on the 
models. Effect estimates, 95% CIs and p values, will be 
calculated. As a complementary analysis, Cox regression 
on time-to-event model will be used to analyse secondary 
outcomes (eg, survival, first recurrent suicide attempts 
and first recurrent acts of self-injury) if data will be avail-
able. Multiple imputations will be performed on the data, 
if some data will be not available.
The following subgroup analyses will be conducted: 
(1) Diagnosis (those with personality disorders). (2) 
Less than 18 years of age. (3) By emergency care facility. 
The subgroup analysis will be performed on the primary 
outcome and the secondary outcomes.
We plan to include 200 patients. If we assume that a 
power analysis indicates 100 non-exposure patients whose 
prior data indicate an event proportion of 0.1 and 100 
exposure patients with an event proportion of 0.25, the 
statistical power will be 0.802 with an α level of 0.05.
safety management
The study group will design a counselling system to 
enable case managers to consult each other about case 
management interventions. The on-site research staff at 
the participating hospitals will take necessary and appro-
priate actions to ensure the safety of participants if a 
serious adverse event occurs or if a participant is at immi-
nent risk of suicide during the study. The on-site research 
staff will contact the on-site research coordinator at the 
hospital.
The assertive case management intervention has 
been adopted by the national medical payment system 
in Japan; therefore, we do not anticipate any negative 
health impact from the research itself. If health issues 
arise among any of the participants, these will be handled 
through the normal protocols of medical care provision.
strengths and limitations
Strengths
This study follows on from the ACTION-J trial, a 
randomised-controlled trial that demonstrated the effec-
tiveness of an assertive case management intervention for 
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reducing the short-term risk of repeated suicide attempts 
after discharge from emergency departments.10 The 
ACTION-J study has also shown that the assertive case 
management programme is feasible.10 With the recent 
introduction of the assertive case management interven-
tion payment scheme, the implementation and feasibility 
of the ACTION-J assertive case management programme 
in real world clinical settings (and the factors influencing 
feasibility, fidelity and dissemination of the programme) 
need investigation. As the national medical fee system 
covers interventions for suicide attempters, participating 
facilities can obtain funding for this intervention. Thus, 
we believe that the study protocol has high feasibility.
Limitations
As the national medical fee payment scheme for the 
assertive case management intervention has just been 
launched, the number of participating medical facilities 
is limited.
The number of case managers varies among facilities. In 
the case of facilities with only one or a few case managers, 
it will be hard to discriminate between the effect of facility 
characteristics and the effect of case manager characteris-
tics on the outcome variables.
Compliance
The case management implementation rate at 24 weeks 
(6 months) postregistration is the primary outcome. 
Quality assessment of case management and treatment 
adherence are the secondary outcomes.
Patient and public involvement
This study is a disseminating research. Participation of 
patients is not for development of new medical interven-
tion methods. The patients are not directly involved in 
the study design and conduct of the present study.
EthICs And dIssEMInAtIon
The rights and welfare of study participants will be 
protected according to the World Medical Association 
Declaration of Helsinki: Ethical Principles for Medical 
Research Involving Human Subjects. This study complies 
with the ethical guidelines of the Japanese Ministry of 
Health, Labour and Welfare. Ethical validity, including 
the safety, scientific legitimacy and reliability of results, 
will be ensured and approved by the Research Ethical 
Committee of Sapporo Medical University (registered, 
282–81), and the institutional review boards of each 
participating facility, Institutional Review Boards of 
Nara Medical University (registered, 1422), Institutional 
Review Boards of Kindai University(registered, 28–144), 
Institutional Review Boards of Kumamoto Medical 
Centre (registered, 721), Institutional Review Boards 
of Kansai Medical University (registered, T28-15), Insti-
tutional Review Boards of Keio University (registered, 
20160310), Institutional Review Boards of Japan Medical 
University (registered, 28-01-708), Institutional Review 
Boards of Iwate Medical University (registered, H28-96), 
and Institutional Review Boards of University of Occupa-
tional and Environmental Health (registered, H29-139). 
Written informed consent and assent will be obtained 
from participants. If important protocol modifications 
are made, they will be submitted to the Research Ethical 
Committee of Sapporo Medical University and the institu-
tional review boards of each participating facility.
Finance and insurance
This work was supported in part by a Research and Devel-
opment Grant for Comprehensive Research for Persons 
with Disabilities (Mental Disorder Area) by the Japan 
Agency for Medical Research and Development.
reporting and dissemination
The principal investigator will have access to the final 
study data set. The principal investigator will decide the 
authorship eligibility, and the results of this study will be 
presented at national and international meetings and 
published in a scientific journal. Participants will not be 
individually notified of the study results.
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